Mitochondrial NCLX couples glucagon- and PDE2A-Dependent signals to regulate hepatic lipid metabolism
Molecular Metabolism · 2026-11 · 113 · 102433
DOI: 10.1016/j.molmet.2026.102433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Metabolism, 2026-11. Verfasst von Essam A Assali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, Ben Gurion University, Beer-Sheva, 8410501, Israel; Department of Medicine, Endocrinology, David Geffen Sc…. Hauptthemen laut MEDLINE: Glucagon, Lipid Metabolism, Liver, Cyclic Nucleotide Phosphodiesterases, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Arkansas Department of Agriculture, National Institutes of Health.
Abstract (Originalsprache)
Mitochondrial calcium signaling, particularly its glucagon-mediated oscillatory dynamics, plays a pivotal role in regulating hepatic metabolism and is known to be disrupted in steatotic liver disease. We recently identified the mitochondrial Na+/Ca2+exchanger NCLX as a key mediator of glucagon-induced mitochondrial calcium oscillations, essential for proper gluconeogenic function. Here, using hepatocyte-specific NCLX knockout (cKO) mice, we demonstrate that NCLX is critical for intrahepatic lipolysis and fatty acid oxidation (FAO); its loss impairs glucagon-stimulated lipid droplet catabolism and blunts FAO. Mechanistically, we find that NCLX deficiency disrupts allosteric activation of lipolytic enzymes and increases CPT1 sensitivity to malonyl-CoA-mediated inhibition, resulting in defective lipolysis and FAO. We further show that glucagon regulates hepatic NCLX via cAMP/PKA-dependent phosphorylation at NCLX Ser258. Notably, PDE2A acts as a negative regulator of this pathway by degrading mitochondrial cAMP. Hepatic mitochondrial PDE2A abundance and cAMP-degrading activity are elevated in HFD, and in vivo BAY 60-7550 treatment suppresses mitochondrial cAMP degradation and augments PKA signaling in steatotic livers. Pharmacologic inhibition of PDE2A with BAY 60-7550 enhances NCLX phosphorylation, restores mitochondrial calcium efflux and oscillations, and stimulates FAO in an NCLX-dependent manner. Importantly, we uncover that cAMP/PKA-dependent phosphorylation of NCLX at Ser258 is suppressed in human steatotic livers, and that pharmacologic inhibition of PDE2A ameliorates hepatic FAO and steatosis in both dietary and genetic MASLD models. Collectively, our findings establish the glucagon-PDE2A-PKA-NCLX signaling axis as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, Ben Gurion University, Beer-Sheva, 8410501, Israel; Department of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, US…
- Department of Physiology and Cell Biology, Ben Gurion University, Beer-Sheva, 8410501, Israel.
- Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, 91120, Israel.
- Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, 45267, United States.
- Department of Medicine, Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, US; Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, CA,…
- Department of Physiology and Cell Biology, Ben Gurion University, Beer-Sheva, 8410501, Israel. Electronic address: sekler@bgu.ac.il.
Förderung
- NIDDK NIH HHS
- Arkansas Department of Agriculture
- National Institutes of Health
- Israel Science Foundation
Zitieren
APA
Assali, E. A., Taha, M., Salhab, A., Amer, J., Krishnan, K. C., Kostic, M., Veliova, M., Brownstein, A. J., Shirihai, O. S., Safadi, R., & Sekler, I. (2026). Mitochondrial NCLX couples glucagon- and PDE2A-Dependent signals to regulate hepatic lipid metabolism. Molecular Metabolism, 113, 102433. https://doi.org/10.1016/j.molmet.2026.102433
Vancouver
Assali EA, Taha M, Salhab A, Amer J, Krishnan KC, Kostic M, et al. Mitochondrial NCLX couples glucagon- and PDE2A-Dependent signals to regulate hepatic lipid metabolism. Molecular Metabolism. 2026;113:102433. doi:10.1016/j.molmet.2026.102433
BibTeX
@article{Assali2026,
author = {Assali, Essam A and Taha, Mahmoud and Salhab, Ahmad and Amer, Johnny and Krishnan, Karthickeyan Chella and Kostic, Marko and Veliova, Michaela and Brownstein, Alexandra J and Shirihai, Orian S and Safadi, Rifaat and Sekler, Israel},
title = {Mitochondrial NCLX couples glucagon- and PDE2A-Dependent signals to regulate hepatic lipid metabolism},
journal = {Molecular Metabolism},
year = {2026},
volume = {113},
pages = {102433},
doi = {10.1016/j.molmet.2026.102433}
}
EUVIMED